IV Infusion/Bolus Pk normalisation [Dissolution / BCS / IVIVC]

posted by pharm07 – India, 2021-06-24 09:48 (1117 d 20:08 ago) – Posting: # 22432
Views: 1,934

❝ Usually AUC is the parameter you can compare, if you are looking to generate absolute bioavailability details. However, your dose selection depends upon the bioavailability of extravascular administration.


❝ However, I dont understand the selection of IV lower strength and oral higher strength. Do you have any correlation on data?


Hi, Thanks for your inputs.

To be very specific, if i need to validate the predicted p.o. profile from IV Infusion which is a lower dose than oral, then how to scaleup pk parameter to validate oral predictive profile?

For eg, I have IV infusion 10 mg and i wanted to validate the 80mg oral.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Regards,
pharm07

Complete thread:

UA Flag
Activity
 Admin contact
23,101 posts in 4,857 threads, 1,644 registered users;
90 visitors (0 registered, 90 guests [including 9 identified bots]).
Forum time: 05:57 CEST (Europe/Vienna)

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5